Literature DB >> 16671213

Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16671213

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  66 in total

1.  A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.

Authors:  Clayton Harro; David Sack; A Louis Bourgeois; R Walker; Barbara DeNearing; Andrea Feller; Subhra Chakraborty; Charlotte Buchwaldt; Michael J Darsley
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

2.  Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.

Authors:  Arthur K Turner; Jonathan C Stephens; Juliet C Beavis; Judith Greenwood; Cornelia Gewert; Roger Randall; Donna Freeman; Michael J Darsley
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

Review 3.  Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.

Authors:  Arne Taxt; Rein Aasland; Halvor Sommerfelt; James Nataro; Pål Puntervoll
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

4.  A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation.

Authors:  Jason W Sahl; Hans Steinsland; Julia C Redman; Samuel V Angiuoli; James P Nataro; Halvor Sommerfelt; David A Rasko
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

5.  Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

Review 6.  Economics and financing of vaccines for diarrheal diseases.

Authors:  Sarah M Bartsch; Bruce Y Lee
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

7.  The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.

Authors:  Michael J Darsley; Subhra Chakraborty; Barbara DeNearing; David A Sack; Andrea Feller; Charlotte Buchwaldt; A Louis Bourgeois; Richard Walker; Clayton D Harro
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

8.  Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Escherichia coli.

Authors:  Abhisek Ghosal; Rudra Bhowmick; Rajat Banerjee; Sandipan Ganguly; S Yamasaki; T Ramamurthy; T Hamabata; Nabendu Sekhar Chatterjee
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.

Authors:  Koushik Roy; David Hamilton; Kenneth P Allen; Mildred P Randolph; James M Fleckenstein
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

10.  Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies.

Authors:  Xiaosai Ruan; Donald C Robertson; James P Nataro; John D Clements; Weiping Zhang
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.